2022 Investor Day

A focus on our global innovation ecosystem

After a three-year interruption, we were delighted to revive our Investor Day concept, where we offered over 90 investors and analysts from close to 10 countries a smelling, tasting and touching experience at our Zurich Innovation Centre in Kemptthal. 

Our Heads of Science and Technology of our two business divisions, along with their teams, had the opportunity to connect directly with investors and analysts, through a combination of presentations and thematic breakout sessions.  

2022 Investor Days

CEO Gilles Andrier opened the meeting with the history of our presence in Kemptthal and the importance of innovation at Givaudan. He went on to reiterate our 2025 targets of 4-5% organic growth and FCF of over 12% of sales over the five-year period. He ended his presentation with the introduction of the 3 pillars to Givaudan’s innovation approach:

  • Ingredients and process discovery: to enable the discovery of highly specialised ingredients used in formulations,
  • Solutions for consumer products: driving creative design solutions through consumer knowledge and scientific expertise, and
  • Co-creation: ensuing a focused yet expansive expertise and scientific knowledge in adjacent spaces and to ensure consumer relevancy

Fabio Campanile, Head of Science and Technology Taste & Wellbeing, and Jeremy Compton, Head of Science & Technology Fragrance & Beauty presented the main research and innovation priorities for their division. 

Heads of divisional Science and Technology
Left Fabio Campanile, right Jeremy Compton

The lunch was organised around a tasting of plant proteins dishes before participants were invited to join breakout sessions for interactive presentations and discussions around:

  • Health and nutrition offering / sugar reduction taste modulators
  • Colours / antimicrobials and texture     
  • New fragrance ingredients and biotechnology
  • Active Beauty / microbiome  
  • Delivery systems and wellbeing fragrances

If you would like to have a copy of the investor presentation,
> please contact us